Atherosclerosis
Volume 168, Issue 1 , Pages 65-72 , May 2003

Vitamin C, diclophenac, and l-arginine protect endothelium-dependent vasodilation against elevated circulating fatty acid levels in humans

  • Peter Steer

      Affiliations

    • Department of Medical Sciences/Internal Medicine, University Hospital, SE-75185 Uppsala, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46-18-611-3632
    • ,
  • Jonas Millgård

      Affiliations

    • Department of Medical Sciences/Internal Medicine, University Hospital, SE-75185 Uppsala, Sweden
    • ,
  • Samar Basu

      Affiliations

    • Department of Public Health and Caring Sciences, University Hospital, SE-75185 Uppsala, Sweden
    • ,
  • Hans Lithell

      Affiliations

    • Department of Public Health and Caring Sciences, University Hospital, SE-75185 Uppsala, Sweden
    • ,
  • Bengt Vessby

      Affiliations

    • Department of Public Health and Caring Sciences, University Hospital, SE-75185 Uppsala, Sweden
    • ,
  • Christian Berne

      Affiliations

    • Department of Medical Sciences/Internal Medicine, University Hospital, SE-75185 Uppsala, Sweden
    • ,
  • Lars Lind

      Affiliations

    • Department of Medical Sciences/Internal Medicine, University Hospital, SE-75185 Uppsala, Sweden

Received 29 April 2002 ,Revised 23 December 2002 ,Accepted 16 January 2003.

References 

  1. Glasser SP, Selwyn AP, Ganz P. Atherosclerosis: risk factors and the vascular endothelium. Am. Heart J. 1996;131:379–384
  2. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 1993;88:2510–2516
  3. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J. Clin. Invest. 1990;86:228–234
  4. Egashira K, Suzuki S, Hirooka Y, Kai H, Sugimachi M, Imaizumi T, et al. Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension: different responses to acetylcholine and substance P. Hypertension. 1995;25:201–206
  5. Zeiher AM, Schachinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation. 1995;92:1094–1100
  6. Swislocki AL, Chen YD, Golay A, Chang MO, Reaven GM. Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetes. Diabetologia. 1987;30:622–626
  7. Frayn KN, Williams CM, Arner P. Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases?. Clin. Sci. 1996;90:243–253
  8. Steinberg HO, Tarshoby M, Monestel R, et al.  Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J. Clin. Invest. 1997;100:1230–1239
  9. Lundman P, Eriksson M, Schenck-Gustafsson K, Karpe F, Tornvall P. Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease. Circulation. 1997;96:3266–3268
  10. Lind L, Fugmann A, Branth S, Vessby B, Millgård J, Berne C, et al. The impairment in endothelial function induced by non-esterified fatty acids can be reversed by insulin. Clin. Sci. 2000;99:169–174
  11. de Kreutzenberg SV, Crepaldi C, Marchetto S, Calo L, Tiengo A, Del Prato S, et al. Plasma free fatty acids and endothelium-dependent vasodilation: effect of chain-length and cyclooxygenase inhibition. J. Clin. Endocrinol. Metab. 2000;85:793–798
  12. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. l-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J. Clin. Invest. 1992;90:1248–1253
  13. Böger RH, Bode-Böger SM, Szuba A, et al.  Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation. 1998;98:1842–1847
  14. Paolisso G, Gambardella A, Tagliamonte MR, et al.  Does free fatty acid infusion impair insulin action also through an increase in oxidative stress?. J. Clin. Endocrinol. Metab. 1996;81:4244–4248
  15. Rodriguez-Martinez MA, Martinez-Orgado J, Salaices M, Marin J. Impairment of acetylcholine relaxations by malondialdehyde, a marker of lipid peroxidation. J. Vasc. Res. 1996;33:463–470
  16. Jacobs M, Plane F, Bruckdorfer KR. Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta. Br. J. Pharmacol. 1990;100:21–26
  17. Tanner FC, Noll G, Boulanger CM, Lüscher TF. Oxidized low-density lipoproteins inhibit relaxations of porcine coronary arteries: role of scavenger receptor and endothelium-derived nitric oxide. Circulation. 1991;83:2012–2020
  18. Lüscher TF, Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Function. Boca Raton, FL: CRC Press; 1990;
  19. Kontos HA, Wei EP, Ellis EF, Jenkins LW, Povlishock JT, Rowe GT, et al. Appearance of superoxide anion radical in cerebral extracellular space during increased prostaglandin synthesis in cats. Circ. Res. 1985;57:142–151
  20. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 1996;271:C1424–C1437
  21. Lind L, Sarabi M, Millgård J. Methodological aspects of the evaluation of endothelium-dependent vasodilatation in the human forearm. Clin. Physiol. 1998;18:81–87
  22. Lind L, Hall J, Larsson A, Annuk M, Fellström B, Lithell H. Evaluation of endothelium-dependent vasodilation in the human peripheral circulation. Clin. Physiol. 2000;20:440–448
  23. Boberg M, Croon LB, Gustafsson IB, Vessby B. Platelet fatty acid composition in relation to fatty acid composition in plasma and to serum lipoprotein lipids in healthy subjects with special reference to the linolenic acid pathway. Clin. Sci. 1985;68:581–587
  24. Öhrvall M, Tengblad S, Vessby B. Lower tocopherol serum levels in subjects with abdominal adiposity. J. Intern. Med. 1993;234:53–60
  25. Thurnham DI, Davies JA, Crump BJ, Situnayake RD, Davis M. The use of different lipids to express serum tocopherol: lipid ratios for the measurement of vitamin E status. Ann. Clin. Biochem. 1986;23:514–520
  26. Basu S. Radioimmunoassay of 8-iso-prostaglandin F2alpha: an index for oxidative injury via free radical catalysed lipid peroxidation. Prostaglandins Leukot. Essent. Fatty Acids. 1998;58:319–325
  27. Turrens JF, Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 1980;191:421–427
  28. Cardillo C, Kilcoyne CM, Cannon RO, Quyyumi AA, Panza JA. Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension. 1997;30:57–63
  29. Hishikawa K, Oemar BS, Yang Z, Lüscher TF. Pulsatile stretch stimulates superoxide production and activates nuclear factor-kappa B in human coronary smooth muscle. Circ. Res. 1997;81:797–803
  30. Stroes E, Hijmering M, van Zandvoort M, Wever R, Rabelink TJ, van Faassen EE. Origin of superoxide production by endothelial nitric oxide synthase. FEBS Lett. 1998;438:161–164
  31. Hogg N, Darley-Usmar VM, Wilson MT, Moncada S. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem. J. 1992;281:419–424
  32. Darley-Usmar VM, Hogg N, O'Leary VJ, Wilson MT, Moncada S. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic. Res. Commun. 1992;17:9–20
  33. Moore KP, Darley-Usmar V, Morrow J, Roberts LJ. Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite. Circ. Res. 1995;77:335–341
  34. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation. 1998;97:2222–2229
  35. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 1996;97:22–28
  36. Timimi FK, Ting HH, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 1998;31:552–557
  37. Ting HH, Timimi FK, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 1997;95:2617–2622
  38. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF, Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 1996;93:1107–1113
  39. Heitzer T, Just H, Munzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation. 1996;94:6–9
  40. Plotnick GD, Corretti MC, Vogel RA. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. J. Am. Med. Assoc. 1997;278:1682–1686
  41. Kaikkonen J, Porkkala-Sarataho E, Morrow JD, et al.  Supplementation with vitamin E but not with vitamin C lowers lipid peroxidation in vivo in mildly hypercholesterolemic men. Free Radic. Res. 2001;35:967–978
  42. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension. 1997;29:274–279
  43. Bouchard JF, Lamontagne D. Mechanisms of protection afforded by cyclooxygenase inhibitors to endothelial function against ischemic injury in rat isolated hearts. J. Cardiovasc. Pharmacol. 1999;34:755–763
  44. Spieker LE, Noll G, Ruschitzka FT, Maier W, Lüscher TF. Working under pressure: the vascular endothelium in arterial hypertension. J. Hum. Hypertens. 2000;14:617–630
  45. Virdis A, Ghiadoni L, Pinto S, et al.  Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women. Circulation. 2000;101:2258–2263
  46. Perticone F, Ceravolo R, Candigliota M, Ventura G, Iacopino S, Sinopoli F, et al. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Diabetes. 2001;50:159–165
  47. Chowienczyk PJ, Kneale BJ, Brett SE, Paganga G, Jenkins BS, Ritter JM. Lack of effect of vitamin E on l-arginine-responsive endothelial dysfunction in patients with mild hypercholesterolaemia and coronary artery disease. Clin. Sci. 1998;94:129–134
  48. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by l-arginine. Lancet. 1991;338:1546–1550
  49. Clarkson P, Adams MR, Powe AJ, et al.  Oral l-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J. Clin. Invest. 1996;97:1989–1994
  50. Cooke JP, Andon NA, Girerd XJ, Hirsch AT, Creager MA. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation. 1991;83:1057–1062
  51. Mügge A, Elwell JH, Peterson TE, Hofmeyer TG, Heistad DD, Harrison DG. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ. Res. 1991;69:1293–1300
  52. Mitchell JA, Hecker M, Anggard EE, Vane JR. Cultured endothelial cells maintain their l-arginine level despite the continuous release of EDRF. Eur. J. Pharmacol. 1990;182:573–576
  53. Böger RH, Bode-Böger SM, Phivthong-ngam L, et al.  Dietary l-arginine and alpha-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms. Atherosclerosis. 1998;141:31–43
  54. de Man FH, Weverling-Rijnsburger AW, van der Laarse A, Smelt AH, Jukema JW, Blauw GJ. Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation: reversal after lipid-lowering therapy by atorvastatin. Arterioscler. Thromb. Vasc. Biol. 2000;20:744–750
  55. Gutcher GR, Lax AA, Farrell PM. Tocopherol isomers in intravenous lipid emulsions and resultant plasma concentrations. JPEN J. Parenter. Enteral. Nutr. 1984;8:269–273
  56. Krebs M, Stingl H, Nowotny P, Weghuber D, Bischof M, Waldhausl W, et al. Prevention of in vitro lipolysis by tetrahydrolipstatin. Clin. Chem. 2000;46:950–954

PII: S0021-9150(03)00023-6

doi: 10.1016/S0021-9150(03)00023-6

Atherosclerosis
Volume 168, Issue 1 , Pages 65-72 , May 2003

Article Tools

* Image Usage & Resolution